CompaniesRanked

2874 companies · fiscal year 2025 · SEC EDGAR · September 25, 2026

Healthcare companies that spend the most on R&D — page 3

Ranks 201–243 of 243 · Fiscal year 2025 · Data as of September 25, 2026

R&D expense
#CompanyR&D expenseYoY15-year trend
201NeogenNEOGUS$18.4M−12.8%
202Si-BoneSIBNUS$17.4M+5.4%
203Maravai LifesciencesMRVIUS$17.4M−9.5%
204CryoportCYRXUS$17.0M−3.8%
205Mimedx GroupMDXGUS$15.1M+22.3%
206Lemaitre VascularLMATUS$14.1M−9.7%
207DocgoDCGOUS$13.6M+17.0%
208InmodeINMDIL$13.3M+1.4%
209KamadaKMDAIL$13.0M−14.4%
210Catalyst PharmaceuticalsCPRXUS$12.7M+0.5%
211Heron TherapeuticsHRTXUS$12.4M−25.5%
212BioventusBVSUS$12.1M−13.2%
213Cadre HoldingsCDREUS$11.4M+36.0%
214Nu Skin EnterprisesNUSUS$10.8M−16.9%
215Usana Health SciencesUSNAUS$10.7M−7.6%
216TrupanionTRUPUS$9.9M+102.5%
217EvolusEOLSUS$9.6M+4.4%
218TalkspaceTALKUS$9.5M−7.2%
219ProgynyPGNYUS$9.5M—
220OrthopediatricsKIDSUS$9.1M−17.5%
221Ufp TechnologiesUFPTUS$8.6M−17.3%
222Tactile Systems TechnologyTCMDUS$8.5M−4.0%
223NeuroneticsSTIMUS$6.6M−48.4%
224Niagen BioscienceNAGEUS$6.3M+5.2%
225Elite PharmaceuticalsELTPUS$5.7M−27.9%
226Skinhealth SystemsSKINUS$5.6M−10.6%
227Adma BiologicsADMAUS$4.8M+162.7%
228Cronos GroupCRONCA$4.4M+5.2%
229IQVIA HoldingsIQVUS$3.3M−42.4%
230Viemed HealthcareVMDUS$3.0M−1.7%
231Nasus PharmaNSRXIL$2.2M+567.8%
232Xtant MedicalXTNTUS$2.1M−11.9%
233Natures Sunshine ProductsNATRUS$1.9M+11.8%
234Canopy GrowthCGCCA$1.9M−6.6%
235Natural Alternatives InternationalNAIIUS$1.8M−5.3%
236LifevantageLFVNUS$1.4M+100.0%
237Curaleaf HoldingsCURLFUS$805,000−43.3%
238InotivNOTVQUS$405,000−34.4%
239Tilray BrandsTLRYUS$361,000+27.1%
240SNDLSNDLCA$350,005+38.5%
241Lakeland IndustriesLAKEUS$200,0000.0%
242MarimedMRMDUS$93,106—
243LifemdLFMDUS$23,925—

All figures from SEC filings · FY2025 · 43

see sources

Download this data as a CSV →

Companies that spend the most on research and development →

By sector

By country